Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Change in Acquisitions & Divestments (2024 - 2025)

Vistagen Therapeutics' Change in Acquisitions & Divestments history spans 2 years, with the latest figure at $6.0 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 200.15% year-over-year to $6.0 million; the TTM value through Dec 2025 reached $20.5 million, up 173.84%, while the annual FY2025 figure was $12.0 million, N/A changed from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $6.0 million at Vistagen Therapeutics, up from $2.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $8.0 million in Q2 2025 and bottomed at $2.0 million in Q4 2024.